MODERNA, INC.

MRNA

Real-time Estimate - 12/01 07:12:50 am
343.915USD	-2.42%

Turn to zoom

Prev.	352.4300
Open	351.5800
High	357.6399
Low	337.2900
Volume	24 691 302

1h ago	Oil Markets See High Volatility Week with Slight Rally in Asia, OANDA...
2h ago	Euro dollar volatility surges on Omicron, bets on Fed
3h ago	Moderna CEO Says Vaccines Likely Less Effective Against Omicron
3h ago	COVID comeback caps a November to remember in markets

	Short Term	Mid-Term	Long Term
Trend	Bullish	Neutral	Bullish
Resistance	369	484	449
Spread/Res.	-4,4%	-27%	-22%
Spread/Supp.	25%	78%	61%
Support	283	198	219

Sales 2021	17 449 M - -
Net income 2021	11 169 M - -
Net cash 2021	12 344 M - -
P/E ratio 2021	13,4x
Yield 2021	-

Capitalization	143 B 143 B -
EV / Sales 2021	7,48x
EV / Sales 2022	5,84x
Nbr of Employees	1 300
Free-Float	90,5%

Moderna, Inc. is a biotechnology company specialized in research and development of therapeutics and vaccines for infectious, autoimmune and cardiovascular diseases. Turnover per type of income can be broken down as follows:
- Collaboration revenue (79.8%);
- Grant revenue (20.2%).
At the end...

>> Read more

Sector :

Other Biotechnology & Medical Research

Calendar :

2022-03-09 Earnings Release

Trading Rating :

Investor Rating :

Sell Buy
Mean consensus	HOLD
Number of Analysts	18
Last Close Price	352,43 $
Average target price	272,53 $
Spread / Average Target	-22,7%